Literature DB >> 14733595

Factors influencing the ability of nuclear localization sequence peptides to enhance nonviral gene delivery.

K Helen Bremner1, Leonard W Seymour, Ann Logan, Martin L Read.   

Abstract

Nonviral gene delivery is limited by inefficient transfer of DNA from the cytoplasm to the nucleus. Nuclear localization sequence (NLS) peptides have been widely used to exploit intracellular transport mechanisms and promote nuclear uptake of DNA. However, the exact conditions to successfully utilize the properties of NLS peptides are still unclear. In the present study a panel of NLS peptides that bind different transport receptors were compared for their ability to enhance nonviral gene transfer. Several factors such as method of incorporating the NLS peptide, type of NLS peptide, DNA morphology, and proper characterization of NLS peptide/DNA conjugates were identified as important considerations in utilizing NLS peptides to enhance gene transfer. In particular, it was shown that a peptide derived from human T cell leukaemia virus type 1 (HTLV) was able to effectively condense DNA into discrete particles and mediate levels of transgene expression up to 32-fold greater than polylysine-based polyplexes. This is the first study to demonstrate efficient transfection mediated by an importin beta-binding peptide based on the HTLV sequence. Promising results were also achieved with a 7-fold increase in gene expression using a NLS peptide/DNA conjugate formed by site-specific linkage of an extended SV40 peptide via a peptide nucleic acid (PNA) clamp. Altogether, the results from this study should help to define the requirements for successful NLS-enhanced transfection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14733595     DOI: 10.1021/bc034140k

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  22 in total

1.  Polycation-induced cell membrane permeability does not enhance cellular uptake or expression efficiency of delivered DNA.

Authors:  Lisa E Prevette; Douglas G Mullen; Mark M Banaszak Holl
Journal:  Mol Pharm       Date:  2010-06-07       Impact factor: 4.939

Review 2.  Design of modular non-viral gene therapy vectors.

Authors:  Laura De Laporte; Jennifer Cruz Rea; Lonnie D Shea
Journal:  Biomaterials       Date:  2005-10-21       Impact factor: 12.479

Review 3.  Nanotechnology approaches for gene transfer.

Authors:  Karin E Lundin; Oscar E Simonson; Pedro M D Moreno; Eman M Zaghloul; Iulian I Oprea; Mathias G Svahn; C I Edvard Smith
Journal:  Genetica       Date:  2009-06-02       Impact factor: 1.082

4.  INTERCALATING CONJUGATES OF PEG WITH NUCLEAR LOCALIZATION SIGNAL (NLS) PEPTIDE.

Authors:  Serguei V Vinogradov; Hongwei Zhang; Anton Mitin; Galya Warren
Journal:  Polymer Prepr       Date:  2008

5.  Reducible poly(oligo-D-arginine) for enhanced gene expression in mouse lung by intratracheal injection.

Authors:  Young-Wook Won; Hyun Ah Kim; Minhyung Lee; Yong-Hee Kim
Journal:  Mol Ther       Date:  2009-12-22       Impact factor: 11.454

6.  Efficient intracellular gene delivery using the formulation composed of poly (L-glutamic acid) grafted polyethylenimine and histone.

Authors:  Jingjing Deng; Yuting Wen; Cuifeng Wang; Shirong Pan; Huaiyu Gu; Xin Zeng; Lina Han; Yuefang Zhao; Min Feng; Chuanbin Wu
Journal:  Pharm Res       Date:  2010-12-14       Impact factor: 4.200

Review 7.  Non-viral gene therapy for spinal cord regeneration.

Authors:  Li Yao; Sheng Yao; William Daly; William Hendry; Anthony Windebank; Abhay Pandit
Journal:  Drug Discov Today       Date:  2012-05-24       Impact factor: 7.851

8.  Bifunctional chimeric fusion proteins engineered for DNA delivery: optimization of the protein to DNA ratio.

Authors:  Shan Gao; Melissa J Simon; Barclay Morrison; Scott Banta
Journal:  Biochim Biophys Acta       Date:  2009-03

Review 9.  Strategies on the nuclear-targeted delivery of genes.

Authors:  Jing Yao; Ying Fan; Yuanke Li; Leaf Huang
Journal:  J Drug Target       Date:  2013-08-22       Impact factor: 5.121

10.  Peptide-mediated lipofection is governed by lipoplex physical properties and the density of surface-displayed amines.

Authors:  Jennifer C Rea; Annelise E Barron; Lonnie D Shea
Journal:  J Pharm Sci       Date:  2008-11       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.